Sponsor:
Indiana University
Code:
NCT05435547
Conditions
Graves Disease
Hashimoto Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dexamethasone
Placebo
Brief summary:
Conditions
Graves Disease
Hashimoto Disease
Study ID
NCT05435547
Start date
Jun 16, 2023
Status verified date
May, 2026
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Dec 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
76 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Steroids
placebo comparator: placebo
Interventions
Dexamethasone
Placebo
Primary outcome measure
Central contacts
Hannah Allison, MA
hralliso@iu.eduLocations
IU Health North Hospital
Recruiting
Indianapolis, Indiana, United States, 46032
IU Health Methodist Hospital
Recruiting
Indianapolis, Indiana, United States, 46202
IU Health University Hospital
Recruiting
Indianapolis, Indiana, United States, 46202
Sponsor
Indiana University
Last update posted
Aug 5, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Indiana University on 2026-08-05.